除了多巴胺D2受体对手之外,精神分裂症的新治疗点和药物
Aineng Peng1, Jianbo Chai2, Haiyuan Wu1
1Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China.
Neuropsychiatric disease and treatment
|March 25, 2024
概括
精神分裂症的治疗正在发展,超越了多巴胺D2受体阻塞. 新抗精神病药物开发的目标是色胺和血酸盐等受体,为耐火病例提供了希望.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 精神病 疾病 研究 研究 精神病 疾病
背景情况:
- 精神分裂症的发病过程涉及复杂的遗传和神经生物学因素,包括多巴胺,血清素和谷氨酸酸通路.
- 第一代抗精神病药物向多巴胺D2受体,而第二代药物使用双重阻断 (多巴胺和血清素).
- 第三代抗精神病药物探索D2部分激动性和新的点,如D3,5-HT1A,5-HT7和mGlu2/3受体.
研究的目的:
- 为精神分裂症治疗的不断变化的治疗目标提供全面的概述.
- 审查当前和新兴抗精神病药物及其作用机制.
- 为突出研究方向超越多巴胺D2受体对抗性耐火精神分裂症.
主要方法:
- 审查关于精神分裂症病原和抗精神病药物开发的现有文献.
- 治疗点的分析,包括多巴胺,血清,谷氨酸和其它神经递质系统.
- 检查新的药物开发策略,重点关注受体激动或抑制.
主要成果:
- 抗精神病药物开发已经从D2对抗向多目标方法发展.
- 第二代和第三代抗精神病药物提供了更好的副作用概况和对负面症状的疗效.
- 新兴的目标包括NMDARs,GABA,mGlu,胆固醇,5-HT2C和α-2受体,具有有前临床数据的前临床数据.
结论:
- 除了多巴胺D2受体之外,对替代点的研究显著扩大了精神分裂症的治疗选择.
- 调节各种神经递质系统对于开发更有效的抗精神病疗法至关重要.
- 需要进一步的研究来探索新型抗精神病药物候选药物的临床适用性和药理动力学.
更多相关视频
相关概念视频
01:21Antipsychotic Drugs: Typical and Atypical Agents
194
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
194
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
189
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
189
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
610
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
610
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:28Psychosis and Antipsychotic Drugs: Overview
248
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
248
01:23Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228